Combined High-Dose Caspofungin and Liposomal Amphotericin B for Treatment of Azole-Resistant Cerebral Aspergillosis - Institut Pasteur Access content directly
Journal Articles Antimicrobial Agents and Chemotherapy Year : 2021

Combined High-Dose Caspofungin and Liposomal Amphotericin B for Treatment of Azole-Resistant Cerebral Aspergillosis

Fichier principal
Vignette du fichier
aac.00474-21.pdf (376.16 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Licence : Copyright

Dates and versions

pasteur-04173103 , version 1 (28-07-2023)

Licence

Copyright

Identifiers

Cite

A. Pouvaret, A. Duréault, D. Garcia-Hermoso, A. Serris, J. Cohen, et al.. Combined High-Dose Caspofungin and Liposomal Amphotericin B for Treatment of Azole-Resistant Cerebral Aspergillosis. Antimicrobial Agents and Chemotherapy, 2021, 65 (10), pp.e00474-21. ⟨10.1128/AAC.00474-21⟩. ⟨pasteur-04173103⟩
7 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More